Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE...

por Panaccione, Remo, Sandborn, William J, D’Haens, Geert, Wolf, Douglas C, Berg, Sofie, Maa, Jen-fue, Petersson, Joel, Robinson, Anne M
Publicado 2018

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial

por Inoue, Nagamu, Kobayashi, Kiyonori, Naganuma, Makoto, Hirai, Fumihito, Ozawa, Morio, Arikan, Dilek, Huang, Bidan, Robinson, Anne M., Thakkar, Roopal B., Hibi, Toshifumi
Publicado 2017

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn’s Disease Studies

por Panaccione, Remo, Löfberg, Robert, Rutgeerts, Paul, Sandborn, William J, Schreiber, Stefan, Berg, Sofie, Maa, Jen-Fue, Petersson, Joel, Robinson, Anne M, Colombel, Jean-Frederic
Publicado 2019

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

por Louis, Edouard J., Reinisch, Walter, Schwartz, David A., Löfberg, Robert, Robinson, Anne M., Berg, Sofie, Wang, Anthony W., Maa, Jen-fue, Huang, Bidan, Pappalardo, Brandee
Publicado 2018

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

por Loftus, Edward V, Reinisch, Walter, Panaccione, Remo, Berg, Sofie, Alperovich, Gabriela, Bereswill, Mareike, Kalabic, Jasmina, Petersson, Joel, Thakkar, Roopal, Robinson, Anne M, D’Haens, Geert
Publicado 2019

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

por Suzuki, Yasuo, Motoya, Satoshi, Hanai, Hiroyuki, Matsumoto, Takayuki, Hibi, Toshifumi, Robinson, Anne M., Mostafa, Nael M., Chao, Jingdong, Arora, Vipin, Camez, Anne, Thakkar, Roopal B., Watanabe, Mamoru
Publicado 2013

Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2

por Ruemmele, Frank M, Rosh, Joel, Faubion, William A, Dubinsky, Marla C, Turner, Dan, Lazar, Andreas, Eichner, Samantha, Maa, Jen-Fue, Alperovich, Gabriela, Robinson, Anne M, Hyams, Jeffrey S
Publicado 2018

Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease

por Faubion, William A., Dubinsky, Marla, Ruemmele, Frank M., Escher, Johanna, Rosh, Joel, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Reilly, Nattanan, Thakkar, Roopal B., Robinson, Anne M., Lazar, Andreas
Publicado 2017

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial

por Reinisch, Walter, Colombel, Jean-Frédéric, D’Haens, Geert, Sandborn, William J., Rutgeerts, Paul, Geboes, Karel, Petersson, Joel, Eichner, Samantha, Zhou, Qian, Robinson, Anne M., Read, Holly A., Thakkar, Roopal
Publicado 2017

Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial

por Chen, Baili, Gao, Xiang, Zhong, Jie, Ren, Jianlin, Zhu, Xuan, Liu, Zhanju, Wu, Kaichun, Kalabic, Jasmina, Yu, Zhuqing, Huang, Bidan, Kwatra, Nisha, Doan, Thao, Robinson, Anne M., Chen, Min-Hu
Publicado 2020

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

por Colombel, Jean-Frederic, Sandborn, William J, Ghosh, Subrata, Wolf, Douglas C, Panaccione, Remo, Feagan, Brian, Reinisch, Walter, Robinson, Anne M, Lazar, Andreas, Kron, Martina, Huang, Bidan, Skup, Martha, Thakkar, Roopal B
Publicado 2014

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease

por Wu, Kai-Chun, Ran, Zhi Hua, Gao, Xiang, Chen, Minhu, Zhong, Jie, Sheng, Jian-Qiu, Kamm, Michael A, Travis, Simon, Wallace, Kori, Mostafa, Nael M, Shapiro, Marisa, Li, Yao, Thakkar, Roopal B, Robinson, Anne M
Publicado 2016

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA

por Travis, Simon, Feagan, Brian G, Peyrin-Biroulet, Laurent, Panaccione, Remo, Danese, Silvio, Lazar, Andreas, Robinson, Anne M, Petersson, Joel, Pappalardo, Brandee L, Bereswill, Mareike, Chen, Naijun, Wang, Song, Skup, Martha, Thakkar, Roopal B, Chao, Jingdong
Publicado 2017